Contact Us

Tribal

Ascletis Announces Positive Topline Results of Phase Ib Studies of ASC47 Monotherapy in Australia and U.S. FDA Clearance of IND Application for ASC47 in Combination with Semaglutide

ASC47,an adipose-targeted muscle-preserving weight loss drug candidate for the treatment of obesity,demonstrated a half-life of up to 26 days and 40 days,respectively,in Phase Ib single subcutaneous i

Tribal

Mar 12, 2025

AIM Vaccine's Serum-Free Iterative Rabies Vaccine Has Received Production License and Will Submit for Market Registration

Launch of Major Product Expected to Significantly Drive Performance Growth HONG KONG,March 12,2025-- AIM Vaccine Co.,Ltd. (06660.HK),a leading PRC vaccine company,published an announcement on March 12

Tribal

Mar 12, 2025

Global Times: Up Close: President Xi takes part in deliberation of Jiangsu delegation

BEIJING,March 8,2025-- Chinese PresidentXi Jinping,also general secretary of the Communist Party of China Central Committee and chairman of the Central Military Commission,took part in a deliberation

Tribal

Mar 11, 2025

'Stability' of China's diplomacy is a gift to the world: Global Times editorial

BEIJING,March 8,2025-- On Friday,Member of the Political Bureau of the Communist Party of China Central Committee and Foreign Minister WangYi answered questions from Chinese and foreign journalists ab

Tribal

Mar 11, 2025

BEST Inc. Announces Completion of Going Private Transaction

HANGZHOU,China,March 8,2025-- BEST Inc. (NYSE: BEST) ("BEST" or the "Company"),a leading integrated smart supply chain solutions and logistics services provider in China and Southe

Tribal

Mar 11, 2025

CGTN AMERICA & CCTV UN: China in Springtime - Sharing Opportunities with the World

WASHINGTON,March 8,2025-- CGTN America & CCTV UN releases "China in Springtime – Sharing Opportunities with the World."

Tribal

Mar 11, 2025
1 ... 36 37 38 39 40 41 42 ... 117